The interactions of aurein 1.2 with cancer cell membranes.

Here, the interactions of aurein 1.2, a defence peptide, with T98G glioblastoma cell membranes are studied. The peptide induced maximal surface pressure changes of circa 9 mN m(-1) in monolayers of endogenous T98G membrane lipid. Reducing monolayer anionic lipid showed a positive correlation (R(2)>0.91) with decreases in maximal surface pressure changes induced by aurein 1.2 (circa 3 mN m(-1) in the absence of this lipid). Cancer cell membrane invasion by the peptide therefore appears not to be mediated by lipid receptors or specific lipid requirements but rather a general requirement for anionic lipid and/or other negatively charged membrane components.

[1]  T. Sakaeda,et al.  An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. , 2006, Current pharmaceutical design.

[2]  L. Bagatolli,et al.  Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein. , 2005, Biophysical journal.

[3]  J. Ferlay,et al.  Cancer incidence and mortality in Europe, 2004. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[5]  D. Phoenix,et al.  Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes. , 2006, Current protein & peptide science.

[6]  F. Separovic,et al.  Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes , 2004, European Biophysics Journal.

[7]  K. Brandenburg,et al.  Domain V of m-calpain shows the potential to form an oblique-orientated alpha-helix, which may modulate the enzyme's activity via interactions with anionic lipid. , 2002, European journal of biochemistry.

[8]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[9]  L. Llewellyn,et al.  Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance , 2004, Peptides.

[10]  S. Cross.  The molecular pathology of new anti-cancer agents , 2005 .

[11]  Frances Separovic,et al.  Interaction of antimicrobial peptides from Australian amphibians with lipid membranes. , 2003, Chemistry and physics of lipids.

[12]  Y. Nozawa,et al.  Membrane phospholipid composition and membrane fluidity of human brain tumour: a spin label study. , 1987, Neurological research.

[13]  D. Phoenix,et al.  Amphiphilic α-Helical Antimicrobial Peptides and Their Structure / Function Relationships , 2005 .

[14]  D. Phoenix,et al.  Are Oblique Orientated α-Helices Used by Antimicrobial Peptides for Membrane Invasion? , 2005 .

[15]  G. Anantharamaiah,et al.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.

[16]  I. Ojima,et al.  Recent advances in tumor-targeting anticancer drug conjugates. , 2005, Bioorganic & medicinal chemistry.

[17]  L. Dicks,et al.  Mode of action of lipid II-targeting lantibiotics. , 2005, International journal of food microbiology.

[18]  A. Sarasin,et al.  An overview of the mechanisms of mutagenesis and carcinogenesis. , 2003, Mutation research.

[19]  M. Fussenegger,et al.  In vitro assays for anticancer drug discovery--a novel approach based on engineered mammalian cell lines. , 2005, Anti-cancer drugs.

[20]  L. Llewellyn,et al.  Amphibian peptides that inhibit neuronal nitric oxide synthase. Isolation of lesuerin from the skin secretion of the Australian Stony Creek frog Litoria lesueuri. , 2002, European journal of biochemistry.

[21]  G. Sheppard,et al.  Why optimize cancer drugs for ADMET , 2005 .

[22]  C. Leuschner,et al.  Membrane disrupting lytic peptides for cancer treatments. , 2004, Current pharmaceutical design.

[23]  M. Papagianni.  Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. , 2003, Biotechnology advances.

[24]  B. de Kruijff,et al.  An investigation into the lipid interactions of peptides corresponding to the C-terminal anchoring domains of Escherichia coli penicillin-binding proteins 4, 5 and 6. , 1998, Biochimica et biophysica acta.

[25]  S. Ran,et al.  Increased exposure of anionic phospholipids on the surface of tumor blood vessels. , 2002, Cancer research.

[26]  K. Brandenburg,et al.  Investigations into the mechanisms used by the C-terminal anchors of Escherichia coli penicillin-binding proteins 4, 5, 6 and 6b for membrane interaction. , 2002, European journal of biochemistry.

[27]  C. Bucana,et al.  Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. , 1991, Cancer research.

[28]  G. Fimland,et al.  The C-terminal Domain of Pediocin-like Antimicrobial Peptides (Class IIa Bacteriocins) Is Involved in Specific Recognition of the C-terminal Part of Cognate Immunity Proteins and in Determining the Antimicrobial Spectrum* , 2005, Journal of Biological Chemistry.

[29]  Y. Shai,et al.  Host defense peptides as new weapons in cancer treatment , 2005, Cellular and Molecular Life Sciences CMLS.

[30]  Honghua Li,et al.  Carcinogenesis: The more we seek to know the more we need to know – Challenges in the post Genomic Era , 2003, Journal of carcinogenesis.

[31]  Zhinan Xu,et al.  Recent advances in the research and development of human defensins , 2006, Peptides.

[32]  R. Demel.  [49] Monolayers-description of use and interaction , 1974 .

[33]  R. Hancock,et al.  Cationic host defense (antimicrobial) peptides. , 2006, Current opinion in immunology.

[34]  J. Carver,et al.  The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. , 2000, European journal of biochemistry.

[35]  T. Richardson,et al.  Minimising monolayer collapse on Langmuir troughs , 2006 .

[36]  J. Schellens,et al.  Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. , 2006, Trends in pharmacological sciences.

[37]  J. Wallace,et al.  The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis. Part 2. Sequence determination using electrospray mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[38]  Reto Stöcklin,et al.  Anti‐microbial peptides: from invertebrates to vertebrates , 2004, Immunological reviews.